DUBLIN--(BUSINESS WIRE)--The "Indonesia Diagnostic Labs Market, By Provider Type (Hospital Based Diagnostic Labs, Diagnostic Chains, Stand Alone Diagnostic Labs), By Test Type (Pathology v/s Radiology), By End User, By Region, Competition, Forecast & Opportunities, 2017-2027F" report has been added to ResearchAndMarkets.com's offering.

Indonesia diagnostic labs market stood at USD 1,997.95 Million in 2021 and is expected to reach a CAGR of 7.84% during the forecast period. This can be attributed to the growing prevalence of various communicable and non-communicable diseases in the country. Additionally, the growing geriatric population is susceptible to various diseases and requires regular diagnostic checkups for disease diagnosis and treatment, increasing the demand for diagnostic labs. Besides, growing healthcare awareness among the population related to preventive healthcare and early disease diagnosis and treatment is further expected to create lucrative opportunities for market growth.

Growing Prevalence of Diseases

Bacterial, parasitic, and viral gastroenteritis, typhoid fever, and viral hepatitis, among others, are some of Indonesia's most observed diseases requiring accurate diagnosis and treatment. Similarly, the country's prevalence of chronic diseases such as cancer, diabetes, cardiovascular diseases, among others, has significantly increased in recent years. According to Global Cancer Observatory, in 2020, Indonesia reported 396,914 new cancer cases, with breast cancer, cervix uteri, lung cancer, colorectum, and liver cancer being the most prevalent. This has significantly increased the demand for disease diagnosis to provide effective and timely treatment, thereby fueling the growth of diagnostic labs in the country.

Growing Healthcare Expenditure

The improving healthcare infrastructure across Indonesia will increase the number of hospital establishments and diagnostic laboratories across the country. Additionally, the Indonesian government continuously invests in upgrading the existing hospitals' infrastructure. Also, the healthcare expenditure in Indonesia is constantly increasing. It was about 2.9% of the country's GDP in 2019, which is expected to increase in the coming years. This, in turn, will create new opportunities for hospital-based diagnostic labs.

Growing Geriatric Population

In Indonesia, 9.6% of the country's total population was 60 and above in 2019. The increase in the elderly population has further increased the demand for the diagnosis of diseases and disorders. The elderly population is highly susceptible to diseases requiring several diagnostic tests to diagnose the disease condition and provide accurate treatment. This, in turn, is expected to create lucrative opportunities for the growth of the Indonesia diagnostic labs market during the forecast period. Taking the advantage of prevailing geriatric population and the diseases related to them, companies have introduced multiple services in terms of many packages as per the customers' suitability and requirements.

Market Segmentation

Indonesia Diagnostic Labs Market, By Provider Type:

• Hospital Based Diagnostic Labs
• Diagnostic Chains
• Stand Alone Diagnostic Labs

Indonesia Diagnostic Labs Market, By Test Type:

• Pathology
• Radiology

Indonesia Diagnostic Labs Market, By End User:

• Walk-ins
• Referrals
• Corporate Clients

Indonesia Diagnostic Labs Market, By Region:

• Sumatra
• Java
• Celebes
• Borneo
• Rest of Indonesia

Key Topics Covered:

1. Service Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Indonesia Diagnostic Labs Market

5. Voice of Customer

6. Indonesia Diagnostic Labs Market Outlook

7. Indonesia Hospital Based Diagnostic Labs Market Outlook

8. Indonesia Diagnostic Chains Market Outlook

9. Indonesia Stand Alone Diagnostic Labs Market Outlook

10. Market Dynamics

11. Market Trends & Developments

12. Policy & Regulatory Landscape

13. Indonesia Economic Profile

14. Digitalization Across Laboratories in Indonesia

15. List of Diagnostic Labs in Indonesia, By Region

16. Pricing Analysis of Common Tests Offered By Top 5 Companies

17. Competitive Landscape

18. Strategic Recommendations

Companies Mentioned

• Laboratorium Klinik CITO Indraprasta Semarang (CITO)
• Bio Medika Laboratorium Klink Utama
• Prodia Clinical Laboratory
• PT Kimia Farma Diagnostika
• Pramita Lab
• Laboratorium Parahita Diagnostic Center
• PT Indec Diagnostics
• Klinik & Laboratorium Klinik Ultra Medica
• PT Prima Medika Laboratories
• Laboratorium Klinik ABC Pusat

For more information about this report visit https://www.researchandmarkets.com/r/8ul6uh

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900